We first compared Kv1.3 mRNA expression in microglia isolated from SAMP8 mice and senescence-accelerated mouse resistant strain 1 (SAMR1) mice, which serve as a control to SAMP8 mice, at four months of age, an age when AD pathological changes begin to emerge [27]. Here, KCNA3 is linked to Alzheimer disease.